Wörwag Pharma

from Wikipedia, the free encyclopedia
Wörwag Pharma GmbH & Co. KG

logo
legal form GmbH & Co. KG
founding 1971
Seat Boeblingen , GermanyGermanyGermany 
management
  • Monika Wörwag
  • Gerhard Mayer
  • Jochen Schlindwein
Number of employees approx. 1,000
sales 234.1 million euros
Branch Pharmaceutical industry
Website www.woerwagpharma.de
As of December 31, 2019

Wörwag Pharma ( proper spelling in capital letters) is an independent, medium - sized, family - run pharmaceutical company based in Böblingen . It was founded in 1971 by Fritz Wörwag, a pharmacist , and sells both prescription and over-the-counter products and dietary supplements . Wörwag Pharma has specialized in so-called biofactors. These include, for example, vitamins , minerals and trace elements .

history

Foundation phase

In 1965 the city pharmacy was founded in the Zuffenhausen district of Stuttgart . At the beginning of the 1970s, the owner Fritz Wörwag began to manufacture and sell his own pharmaceuticals. This formed the basis for the foundation of Wörwag Pharma in 1971. Among the best known specimens of the first year included Magnerot Classic ( magnesium - orotate ) and Milgamma ( benfotiamine ). To accelerate the development of the business, the company was converted into a corporation in 1977 .

internationalization

Wörwag Pharma developed into a specialist for vitamins and trace elements , but also has a name as a manufacturer of generics . As the first international location outside Germany, a branch was opened in Hungary in 1993, later further branches were added in Eastern Europe , Russia and Central Asia . Wörwag Pharma is now also present in Asian and South American countries, for example in Vietnam and Peru.

Generation change

In 1996, Wörwag Pharma moved its headquarters from Stuttgart to Böblingen. In 2001 the two children Marcus Wörwag and Monika Wörwag took over the management of the company from their father. They continued Wörwag Pharma's expansion course, concentrating above all on biofactors. In 2015 they spun off the generics business to the independent subsidiary AAA-Pharma. In January 2019, Marcus Wörwag moved from the company's management to the advisory board, where he continues to help shape the group's strategic direction.

Products

Wörwag Pharma offers drugs for the prevention and treatment of diabetic comorbidities and secondary diseases, of neuralgia and pain, as well as for maintaining mental fitness. The company's product range comprises a total of 26 biofactor brands in Germany alone. Magnerot and Milgamma are still two strong brands in the Wörwag Pharma range.

  • Magnerot classic

  • Milgamma protect

structure

legal form

Wörwag Pharma GmbH & Co. KG is a limited partnership under German law. Your general partner is Dr. Fritz Wörwag GmbH, a limited liability company . This is wholly owned by the company's founder. In addition, he and other family members are directly or indirectly involved as limited partners . The vast majority of the limited partners' liability contributions are made by the family-owned Wörwag GmbH and Wörwag Pharma Beteiligungs GmbH.

The annual financial statements of Wörwag Pharma GmbH & Co. KG are included in the consolidated financial statements of Wörwag Pharma Beteiligungs GmbH. The latter acts as the parent company for the domestic and foreign subsidiaries. Wörwag Pharma International GmbH controls the international holdings.

management

Since January 2020, the management of Wörwag Pharma has consisted of Monika Wörwag as well as Gerhard Mayer and Jochen Schlindwein, the two commercial directors . All are authorized signatories of Wörwag Pharma GmbH & Co. KG and also managing directors of Dr. Fritz Wörwag GmbH.

  • Monika Wörwag

  • Gerhard Mayer

  • Jochen Schlindwein

Locations

On the Flugfeld , an intermunicipal residential and commercial area between Böblingen and Sindelfingen , Wörwag Pharma is currently building a new company building that meets the company's increased requirements. The planned move is in 2021. In addition to the headquarters in Böblingen, there are currently 19 country offices in Almaty , Baku , Belgrade , Bratislava , Budapest , Chișinău , Cluj-Napoca , Ho Chi Minh City , Hong Kong , Kiev , Lima , Ljubljana , Minsk , Moscow , Beijing , Riga , Sofia , Tashkent , Tbilisi and Warsaw . These control the business in around 35 countries.

Web links

Commons : Wörwag Pharma  - Collection of Images

Individual evidence

  1. ↑ a b Facts and Figures. Wörwag Pharma, accessed on May 7, 2020 .
  2. ↑ Siegfried Hofmann: Medium-sized pharmaceutical companies lack financial strength . In: Handelsblatt . December 2, 2003, p. 16 ( handelsblatt.com [accessed on August 10, 2018]).
  3. ↑ a b These clans are Pharma-Germany. In: Apotheke Adhoc. June 27, 2016, accessed August 10, 2018 .
  4. ↑ a b c d Wörwag Pharma GmbH & Co. KG. In: Business Register. Bundesanzeiger Verlag, accessed on August 10, 2018 (Stuttgart District Court, HRA 242191).
  5. ↑ a b c Vitamins for everyone. In: Deutsche Apotheker Zeitung. June 24, 2016, accessed August 10, 2018 .
  6. ↑ Jan-Philipp Schlecht: Wörwag wants to keep growing. In: Böblinger Bote. July 12, 2018, accessed July 28, 2018 .
  7. ↑ Briefly informed . In: Deutsches Ärzteblatt . No. 18 , 1997 ( aerzteblatt.de [accessed on August 10, 2018]).
  8. ^ Company Overview of Wörwag Pharma GmbH & Co. KG. In: Bloomberg. Retrieved August 1, 2018 .
  9. ↑ a b Karoline Schumbach: Wörwag: Alles Gamma. In: Apotheke Adhoc. March 12, 2013, accessed August 10, 2018 .
  10. ↑ Dr. Wörwag Pharmaceutical Preparations GmbH. In: Business Register. Bundesanzeiger Verlag, accessed on August 10, 2018 (Stuttgart District Court, HRB 7039).
  11. ↑ Ursula Petersen: New products at Wörwag Pharma . In: Deutsches Ärzteblatt . No. 33 , 1992 ( aerzteblatt.de [accessed on August 10, 2018]).
  12. ↑ Andreas Bohne, Siegfried Hofmann: Pharmaceutical industry: copycat drugs are gaining in importance. The generics business is becoming a highly competitive growth market. In: Handelsblatt . September 13, 1996, p. 28 .
  13. ↑ Wörwag on course for expansion. In: Böblinger Bote. Retrieved August 10, 2018 .
  14. ↑ Profile. Wörwag Pharma, accessed on August 10, 2018 .
  15. ↑ Kathrin Haasis: Pharmaceutical company Wörwag moves to the airfield. In: Stuttgarter Zeitung. July 18, 2018, accessed August 10, 2018 .
  16. ^ Wörwag Pharma GmbH. In: Business Register. Bundesanzeiger Verlag, accessed on August 10, 2018 (Stuttgart District Court, HRB 4154).
  17. ↑ Pharmaceutical companies: who belongs to whom? In: Apotheke Adhoc. Retrieved August 10, 2018 .
  18. ^ Wörwag Pharma: Change in company management. Wörwag Pharma, January 9, 2019, accessed January 30, 2019 .
  19. ↑ Products. Wörwag Pharma, accessed on August 10, 2018 .
  20. ↑ a b Dr. Fritz Wörwag GmbH. In: Business Register. Bundesanzeiger Verlag, accessed on August 10, 2018 (Stuttgart District Court, HRB 17815).
  21. ^ Wörwag Pharma Beteiligungs GmbH. In: Business Register. Bundesanzeiger Verlag, accessed on August 10, 2018 (Stuttgart District Court, HRB 17799).
  22. ^ Wörwag Pharma International GmbH. In: Business Register. Bundesanzeiger Verlag, accessed on August 10, 2018 (Stuttgart District Court, HRB 752468).
  23. ↑ Management. Wörwag Pharma, accessed on May 7, 2020 .
  24. ^ Karlheinz Reichert: Gäubote. In: Gäubote. July 7, 2018, accessed August 10, 2018 .
  25. ↑ Kathrin Haasis: Pharmaceutical company Wörwag moves to the airfield. In: Stuttgarter Nachrichten. July 18, 2018, accessed August 30, 2018 .
  26. ↑ locations. Wörwag Pharma, accessed on August 10, 2018 .